BGI takes aim at HiSeq X with new sequencer; ASCO picks Syapse for precision medicine trial;

> BGI's Complete Genomics signed up the first clients for its HiSeq X Ten-rivaling high-throughput Revolocity sequencing system. More

> ASCO picked Syapse Precision Medicine Platform for its Big Pharma-backed TAPUR study. Item

> The Financial Times profiled 23andMe's Anne Wojcicki, describing the CEO as "the freewheeling queen of home DNA testing." Feature (reg. req.)

> Trinity Pharma Solutions rebranded as SHYFT Analytics following the introduction of the latest iteration of its life sciences analytics platform. Release

> Chris4Life Colon Cancer Foundation created a colon cancer-focused clinical trial database to make it easier for people to participate in research. News (PDF)

> Experfy scooped seed funding to build out its marketplace for freelance data scientists. Article (sub. req.)